Evolving treatments for advanced gastric cancer: appraisal of the survival trend
Author:
Affiliation:
1. Clinical and Molecular Medicine Department, Sapienza University, Sant’Andrea Hospital, Rome, Italy
2. Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1184979
Reference92 articles.
1. Cancer statistics, 2013
2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
3. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
4. Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
5. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. lncRNA RMST is associated with the progression and prognosis of gastric cancer via miR-204-5p;Cell Division;2024-04-12
2. TNF-α-1031T/C gene polymorphism as a predictor of malnutrition in patients with gastric cancer;Frontiers in Nutrition;2023-07-18
3. Research advances in the role of gastric cancer‑derived mesenchymal stem cells in tumor progression (Review);International Journal of Molecular Medicine;2020-12-04
4. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p;Bioengineered;2020-01-01
5. Low expression of RecQ‑like helicase 5 is associated with poor prognosis in patients with gastric cancer;Oncology Letters;2019-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3